Vir Biotechnology (VIR) Short Interest Ratio & Short Volume → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free VIR Stock Alerts $9.54 -0.39 (-3.93%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Vir Biotechnology Short Interest DataCurrent Short Volume5,150,000 sharesPrevious Short Volume4,960,000 sharesChange Vs. Previous Month+3.83%Dollar Volume Sold Short$44.14 millionShort Interest Ratio / Days to Cover4.8Last Record DateApril 15, 2024Outstanding Shares134,500,000 sharesFloat Size88,970,000 sharesShort Percent of Float5.79%Today's Trading Volume1,260,618 sharesAverage Trading Volume1,049,088 sharesToday's Volume Vs. Average120% Short Selling Vir Biotechnology ? Sign up to receive the latest short interest report for Vir Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVIR Short Interest Over TimeVIR Days to Cover Over TimeVIR Percentage of Float Shorted Over Time Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Vir Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20245,150,000 shares $44.14 million +3.8%5.8%4.8 $8.57 3/31/20244,960,000 shares $50.24 million -8.7%5.6%4.6 $10.13 3/15/20245,430,000 shares $58.43 million +6.9%6.2%5 $10.76 2/29/20245,080,000 shares $57.10 million +0.6%5.8%4.4 $11.24 2/15/20245,050,000 shares $52.07 million -12.5%5.8%4.4 $10.31 1/31/20245,770,000 shares $54.24 million -5.1%6.6%4.9 $9.40 Get the Latest News and Ratings for VIR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vir Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 1/15/20246,080,000 shares $63.05 million +2.7%6.9%5.1 $10.37 12/31/20235,920,000 shares $59.56 million -6.0%6.7%4.9 $10.06 12/15/20236,300,000 shares $62.75 million +7.5%7.2%5.1 $9.96 11/30/20235,860,000 shares $55.61 million -4.4%6.7%4.1 $9.49 11/15/20236,130,000 shares $59.34 million No Change7.0%4.3 $9.68 10/31/20236,130,000 shares $48.61 million -4.8%7.0%4.5 $7.93 10/15/20236,440,000 shares $53.90 million +0.2%7.4%4.9 $8.37 9/30/20236,430,000 shares $60.25 million +26.6%7.4%4.1 $9.37 9/15/20235,080,000 shares $49.89 million +11.2%5.8%3.3 $9.82 8/31/20234,570,000 shares $57.86 million -9.2%5.4%3.4 $12.66 8/15/20235,030,000 shares $66.09 million +42.1%5.9%4.1 $13.14 7/31/20233,540,000 shares $49.84 million -10.8%4.2%3 $14.08 7/15/20233,970,000 shares $91.67 million -4.3%4.7%3.5 $23.09 6/30/20234,150,000 shares $101.80 million -0.2%4.9%5 $24.53 6/15/20234,160,000 shares $108.08 million -25.5%4.9%5 $25.98 5/31/20235,580,000 shares $148.82 million +10.5%6.6%6.3 $26.67 5/15/20235,050,000 shares $129.48 million +7.5%6.0%5.1 $25.64 4/30/20234,700,000 shares $118.21 million -1.9%5.6%4.6 $25.15 4/15/20234,790,000 shares $117.59 million +11.9%5.7%4.6 $24.55 3/31/20234,280,000 shares $99.60 million -11.2%5.2%4.2 $23.27 3/15/20234,820,000 shares $113.37 million -1.0%5.8%4.8 $23.52 2/28/20234,870,000 shares $111.04 million +10.7%5.9%5.2 $22.80 2/15/20234,400,000 shares $117.57 million +8.9%5.3%5 $26.72 1/31/20234,040,000 shares $119.38 million +8.3%4.9%4.8 $29.55 1/15/20233,730,000 shares $99.11 million -10.1%4.6%4.5 $26.57 12/30/20224,150,000 shares $105.04 million +9.2%5.1%5.1 $25.31 12/15/20223,800,000 shares $95.72 million -5.5%4.7%4.3 $25.19 11/30/20224,020,000 shares $113.44 million -4.5%5.0%4.2 $28.22 11/15/20224,210,000 shares $115.14 million -4.3%5.3%4.2 $27.35 10/31/20224,400,000 shares $96.71 million +4.3%5.6%4 $21.98 10/15/20224,220,000 shares $87.23 million -14.9%5.4%4 $20.67 9/30/20224,960,000 shares $95.63 million +8.3%6.3%4.8 $19.28 9/15/20224,580,000 shares $93.02 million -6.5%5.9%4.2 $20.31 8/31/20224,900,000 shares $116.38 million -14.0%6.3%4.7 $23.75The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read VIR Short Interest - Frequently Asked Questions What is Vir Biotechnology's current short interest? Short interest is the volume of Vir Biotechnology shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 5,150,000 shares of VIR short. 5.79% of Vir Biotechnology's shares are currently sold short. Learn More on Vir Biotechnology's current short interest. What is a good short interest ratio for Vir Biotechnology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VIR shares currently have a short interest ratio of 5.0. Learn More on Vir Biotechnology's short interest ratio. Which institutional investors are shorting Vir Biotechnology? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Vir Biotechnology: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Vir Biotechnology? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.79% of Vir Biotechnology's floating shares are currently sold short. Is Vir Biotechnology's short interest increasing or decreasing? Vir Biotechnology saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 5,150,000 shares, an increase of 3.8% from the previous total of 4,960,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Vir Biotechnology's float size? Vir Biotechnology currently has issued a total of 134,500,000 shares. Some of Vir Biotechnology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vir Biotechnology currently has a public float of 88,970,000 shares. How does Vir Biotechnology's short interest compare to its competitors? 5.79% of Vir Biotechnology's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Vir Biotechnology: Innoviva, Inc. (18.46%), Relay Therapeutics, Inc. (8.05%), CureVac (4.57%), Beam Therapeutics Inc. (16.00%), Avid Bioservices, Inc. (16.26%), Allogene Therapeutics, Inc. (29.95%), Twist Bioscience Co. (21.04%), Fate Therapeutics, Inc. (16.62%), Replimune Group, Inc. (18.75%), bluebird bio, Inc. (29.83%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Vir Biotechnology stock? Short selling VIR is an investing strategy that aims to generate trading profit from Vir Biotechnology as its price is falling. VIR shares are trading down $0.33 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vir Biotechnology? A short squeeze for Vir Biotechnology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VIR, which in turn drives the price of the stock up even further. How often is Vir Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VIR, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: INVA Short Squeeze RLAY Short Squeeze CVAC Short Squeeze BEAM Short Squeeze CDMO Short Squeeze ALLO Short Squeeze TWST Short Squeeze FATE Short Squeeze REPL Short Squeeze BLUE Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VIR) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarningsWatch this FREE trading tutorial while it’s still availableInvestorPlace